Interactive Investor
>>

Design Therapeutics Inc (NASDAQ:DSGN) Share Price

DSGN

Design Therapeutics Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

NASDAQ:DSGN

US25056L1035

USD

Loading...

Loading Comparison

Latest DSGN News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News